15300G | Biognost® IgG FITC conjugate, 3 ml | 16 | 2 | 1 | 4 | 0 |
01C65433F | Biognost® Adenovirus FITC conjugate, MAB | 16 | 1 | 3 | 2 | 0 |
AD-3101 | Biognost® Adenovirus IgG, positive control | 17 | 3 | 2 | 1 | 0 |
AD-3102 | Biognost® Adenovirus IgM, positive control | 16 | 3 | 4 | 3 | 0 |
AD-3106 | Biognost® Adenovirus slide, 6 wells | 17 | 2 | 5 | 2 | 0 |
AD-3112 | Biognost® Adenovirus slide, 12 wells | 13 | 0 | 2 | 1 | 0 |
6402 | Biognost® Adrenal cortex ab, positive control | 13 | 1 | 3 | 3 | 0 |
6404 | Biognost® Adrenal cortex ab slide, monkey adrenal cortex sections; 4 wells | 14 | 2 | 6 | 8 | 0 |
5201 | Biognost® AKA (keratin) IgG, positive control | 13 | 0 | 1 | 1 | 0 |
2202 | Biognost® AMA, positive control | 15 | 2 | 1 | 3 | 0 |
2004 | Biognost® AMA slide, rat kidney sections, 4 wells | 14 | 2 | 9 | 13 | 0 |
AN-1205 | Biognost® ANA centromere, positive control | 13 | 0 | 0 | 2 | 0 |
1202 | Biognost® ANA homogeneous, positive control | 13 | 2 | 3 | 3 | 0 |
AN-1204 | Biognost® ANA nucleolar, positive control | 13 | 0 | 1 | 5 | 0 |
AN-1006 | Biognost® ANA slide, HEp-2 cells, 6 wells | 13 | 0 | 4 | 2 | 0 |
AN-1012 | Biognost® ANA slide, HEp-2 cells, 12 wells | 16 | 0 | 14 | 24 | 0 |
5304 | Biognost® ASA slide, monkey proximal esophagus sections; 4 wells | 14 | 3 | 7 | 8 | 0 |
5203 | Biognost® ATA (TPO and TG), positive control | 13 | 0 | 0 | 2 | 0 |
2134 | Biognost® Autoscreen 3 slide, rat liver, -kidney, -stomach, triple sections; 4 wells | 15 | 1 | 13 | 21 | 0 |
30-2103 | Biognost® B. pertussis, B. parapertussis, H. influenzae slide, control slide, one spezies per well | 15 | 0 | 2 | 0 | 0 |
BH-1601 | Biognost® Bartonella henselae IgG, positive control | 17 | 5 | 4 | 8 | 0 |
BH-1602 | Biognost® Bartonella henselae IgM, positive control | 18 | 1 | 5 | 4 | 0 |
BH-1606 | Biognost® Bartonella henselae slide, 6 wells | 16 | 5 | 5 | 23 | 0 |
BH-1612 | Biognost® Bartonella henselae slide, 12 wells | 15 | 3 | 8 | 48 | 0 |
BQ-8601 | Biognost® Bartonella quintana IgG, positive control | 13 | 0 | 0 | 5 | 0 |
1111A | Biognost® Biognost® autoantibodies, negative control | 13 | 5 | 4 | 6 | 0 |
CA24-7401 | Biognost® Biognost® Coxsackie virus A24 IgG, positive control | 6 | 3 | 1 | 3 | 0 |
30-2005 | Biognost® Bordetella parapertussis FITC, polyclonal conjugate | 13 | 1 | 1 | 3 | 0 |
30-2001 | Biognost® Bordetella parapertussis IgG, positive control | 16 | 1 | 2 | 1 | 0 |
36-2012 | Biognost® Bordetella parapertussis slide, 12 wells | 18 | 0 | 5 | 5 | 0 |
30-2006 | Biognost® Bordetella parapertussis slide*, 6 wells | 15 | 3 | 4 | 2 | 1 |
36-2005 | Biognost® Bordetella pertussis FITC, polyclonal conjugate; 2 ml | 14 | 2 | 1 | 2 | 0 |
36-2004 | Biognost® Bordetella pertussis IgA, positive control | 16 | 0 | 3 | 3 | 0 |
36-2001 | Biognost® Bordetella pertussis IgG, positive control | 17 | 2 | 0 | 4 | 0 |
36-2002 | Biognost® Bordetella pertussis IgM, positive control | 17 | 3 | 2 | 4 | 0 |
36-2006 | Biognost® Bordetella pertussis slide, 6 wells | 17 | 4 | 3 | 5 | 1 |
12130507K | Biosave® Borrelia ab latex kit, Agglutination | 13 | 0 | 0 | 1 | 0 |
36-6104 | Biognost® Borrelia burgdorferi IgA, positive control | 13 | 0 | 1 | 0 | 0 |
36-6101 | Biognost® Borrelia burgdorferi IgM, positive control | 14 | 2 | 2 | 2 | 0 |
36-6102 | Biognost® Borrelia burgdorferi IgM, positive control | 15 | 1 | 3 | 4 | 0 |
36-6112 | Biognost® Borrelia burgdorferi slide, 12 wells | 14 | 3 | 7 | 19 | 0 |
7606 | Biognost® C-, P-ANCA slide, ethanol fixed human neutrophil granulocytes; 6 wells | 15 | 4 | 4 | 15 | 0 |
7612 | Biognost® C-, P-ANCA slide, ethanol fixed human neutrophil granulocytes; 12 wells | 16 | 0 | 4 | 18 | 0 |
7601 | Biognost® C-ANCA, positive control | 17 | 2 | 3 | 3 | 0 |
40-1004 | Biognost® Candida albicans IgA, positive control | 4 | 1 | 2 | 0 | 0 |
40-1001 | Biognost® Candida albicans IgG, positive control | 14 | 2 | 2 | 1 | 0 |
40-1002 | Biognost® Candida albicans IgM, positive control | 14 | 2 | 3 | 3 | 0 |
40-1006 | Biognost® Candida albicans slide, 6 wells | 14 | 2 | 3 | 5 | 0 |
40-1012 | Biognost® Candida albicans slide, 12 wells | 15 | 0 | 5 | 6 | 0 |
5404 | Biognost® CMA slide, monkey cardiac muscle sections; 4 wells | 14 | 1 | 3 | 8 | 0 |
IF020101 | Biognost® Coxiella burnetii IgG, positive control | 14 | 3 | 2 | 10 | 0 |
IF020102 | Biognost® Coxiella burnetii IgM, positive control | 1 | 2 | 0 | 0 | 0 |
IF0201 | Biognost® Coxiella burnetii slide, phase 1 and phase 2 spots on each well | 14 | 4 | 2 | 5 | 0 |
CA24-7406 | Biognost® Coxsackie virus A24 slide, 6 wells | 12 | 3 | 1 | 4 | 0 |
CA9-6401 | Biognost® Coxsackie virus A9 IgG, positive control | 16 | 4 | 2 | 6 | 0 |
CA9-6406 | Coxsackie virus A9 slide, 6 wells | 13 | 2 | 2 | 2 | 0 |
CA9-6412 | Biognost® Coxsackie virus A9 slide, 12 wells | 13 | 1 | 1 | 4 | 0 |
CB-3301 | Biognost® Coxsackie virus B1-6 IgG, positive control | 14 | 2 | 3 | 4 | 0 |
CB-3302 | Biognost® Coxsackie virus B1-6 IgM, positive control | 13 | 2 | 1 | 1 | 0 |
CB-3306 | Biognost® Coxsackie virus B1-6 slide, 6 wells | 14 | 2 | 6 | 8 | 0 |
CB-3312 | Biognost® Coxsackie virus B1-6 slide, 12 wells | 13 | 0 | 5 | 16 | 0 |
140100 | Biosave® Cryptococcus neoformans Ag Latex Kit, Agglutination | 15 | 0 | 1 | 3 | 0 |
NA-5101 | Biognost® EBNA antibodies, positive control | 12 | 1 | 0 | 1 | 0 |
EAD-5401 | Biognost® EBV-EA diffus IgG, positive control | 15 | 1 | 7 | 14 | 0 |
EAD-5412 | Biognost® EBV-EA diffus slide, 12 wells | 13 | 0 | 1 | 2 | 0 |
EAR/D-5312 | Biognost® EBV-EA restricted & diffus slide, 12 wells | 12 | 0 | 0 | 1 | 0 |
NA-5112 | Biognost® EBV-EBNA 1-4 slide, 12 wells | 12 | 1 | 1 | 0 | 0 |
EB-5004 | Biognost® EBV-VCA IgA, positive control | 17 | 0 | 1 | 3 | 0 |
EB-5001 | Biognost® EBV-VCA IgG, positive control | 17 | 8 | 4 | 8 | 0 |
EB-5002 | Biognost® EBV-VCA IgM, positive control | 16 | 6 | 3 | 3 | 0 |
EB-5006 | Biognost® EBV-VCA slide, 6 wells | 15 | 8 | 4 | 5 | 0 |
EB-5012 | Biognost® EBV-VCA slide, 12 wells | 16 | 2 | 7 | 13 | 0 |
1000401 | Biognost® Echinococcus granulosus ab, positive control | 14 | 4 | 2 | 4 | 0 |
10004 | Biognost® Echinococcus granulosus slide, scolex sections | 15 | 5 | 2 | 7 | 0 |
EC-4406 | Biognost® Echovirus E4, E6, E9, E11, E30, E34 slide, 6 wells | 14 | 2 | 2 | 5 | 0 |
EC-4412 | Biognost® Echovirus E4, E6, E9, E11, E30, E34 slide, 12 wells | 17 | 0 | 10 | 11 | 0 |
EC-4401 | Biognost® Echovirus IgG, positive control | 14 | 5 | 2 | 4 | 0 |
IF1010 | Biognost® Ehrlichia chaffeensis IgG, positive control | 13 | 2 | 5 | 2 | 0 |
IF1001 | Biognost® Ehrlichia chaffeensis slide, 12 wells | 13 | 0 | 5 | 1 | 0 |
5314 | Biognost® EmA IgA slide, monkey distal esophagus slide; 4 wells | 15 | 1 | 6 | 32 | 0 |
50-1001 | Biognost® Entamoeba histolytica IgG, positive control | 13 | 1 | 2 | 4 | 0 |
50-1002 | Biognost® Entamoeba histolytica IgM, positive control | 13 | 1 | 2 | 5 | 0 |
50-1006 | Biognost® Entamoeba histolytica slide, 6 wells | 16 | 2 | 1 | 3 | 0 |
5602 | Biognost® GBM ab, positive control | | 0 | 1 | 4 | 0 |
5614 | Biognost® GBM slide, monkey kidney sections; 4 wells | 15 | 2 | 2 | 9 | 0 |
50-2001 | Biognost® Giardia lamblia IgG, positive control | 13 | 3 | 2 | 3 | 0 |
50-2006 | Biognost® Giardia lamblia slide, 6 wells | 14 | 7 | 7 | 6 | 1 |
1800 | Biognost® Guinea pig complement, EBNA ACIF, lyophilzed | 15 | 0 | 4 | 8 | 0 |
15301C | Biognost® Guinea pig complement FITC conjugate, Evans blue; 3 ml | 12 | 1 | 3 | 0 | 0 |
30-1001 | Biognost® Haemophilus influenzae IgG, positive control | 15 | 2 | 2 | 5 | 0 |
30-1006 | Biognost® Haemophilus influenzae slide, 6 wells | 16 | 2 | 4 | 6 | 0 |
HP-3204 | Biognost® Helicobacter pylori IgA, positive control | 17 | 2 | 1 | 2 | 0 |
HP-3201 | Biognost® Helicobacter pylori IgG, positive control | 16 | 2 | 1 | 2 | 0 |
HP-3212 | Biognost® Helicobacter pylori slide, 12 wells | 17 | 3 | 1 | 3 | 0 |
HS1-3012 | Biognost® Herpes simplex virus 1 (HSV 1) slide, 12 wells | 15 | 1 | 3 | 5 | 0 |
HS2-4012 | Biognost® Herpes simplex virus 2 (HSV 2) slide, 12 wells | 15 | 3 | 2 | 3 | 0 |
HHV6-4301 | Biognost® HHV 6 IgG positive control, positive control | 16 | 3 | 1 | 5 | 0 |
HHV6-4302 | Biognost® HHV 6 IgM, positive control | 12 | 2 | 1 | 1 | 0 |
HHV6-4306 | Biognost® HHV 6 slide, Human Herpes virus 6; 6 wells | 15 | 3 | 0 | 4 | 0 |
HHV6-4312 | Biognost® HHV 6 slide, Human Herpes virus 6; 12 wells | 15 | 0 | 2 | 8 | 0 |
HS-3004 | Biognost® HSV 1+2 IgA, positive control | 13 | 0 | 0 | 1 | 0 |
HS-3001 | Biognost® HSV 1+2 IgG, positive control | 16 | 3 | 2 | 6 | 0 |
HS-3002 | Biognost® HSV 1+2 IgM, positive control | 13 | 4 | 2 | 5 | 0 |
01C65143M | Biognost® HSV1 FITC Konjugat, MAB | 12 | 0 | 1 | 1 | 0 |
QHS-3504 | Biognost® HSV1/HSV2 ag control slide, 1 well HSV1, 1 well HSV2, 2 wells non infected | 15 | 0 | 1 | 6 | 0 |
01C65163M | Biognost® HSV2 FITC conjugate, MAB | 12 | 0 | 1 | 1 | 0 |
5502 | Biognost® ICA, positive control | 13 | 1 | 0 | 4 | 0 |
4504 | Biognost® ICA (islet cell ab) slide, rat pancreas sections, 4 wells | 2 | 1 | 0 | 0 | 0 |
1501A | Biognost® IgA FITC conjugate, Evans blue; 2 ml | 3 | 0 | 0 | 1 | 0 |
15301A | Biognost® IgA FITC conjugate, Evans blue; 3 ml | 15 | 3 | 2 | 1 | 0 |
151001A | Biognost® IgA FITC conjugate, Evans blue; 10 ml | 13 | 19 | 1 | 1 | 0 |
1500G | Biognost® IgG FITC conjugate, 2 ml | 14 | 0 | 2 | 3 | 0 |
1501G | Biognost® IgG FITC conjugate, Evans blue; 2 ml | 13 | 3 | 1 | 4 | 0 |
1512G | Biognost® IgG FITC conjugate, monkey tissue; 2 ml | | 0 | 1 | 1 | 0 |
15301G | Biognost® IgG FITC conjugate, Evans blue; 3 ml | 16 | 90 | 1 | 3 | 0 |
151000G | Biognost® IgG FITC conjugate, 10 ml | 11 | 1 | 2 | 1 | 0 |
151001G | Biognost® IgG FITC conjugate, Evans blue; 10 ml | 12 | 5 | 2 | 5 | 0 |
1501M | Biognost® IgM FITC conjugate, Evans blue; 2 ml | 13 | 1 | 1 | 1 | 0 |
15301M | Biognost® IgM FITC conjugate, Evans blue; 3 ml | 18 | 65 | 1 | 3 | 0 |
151001M | Biognost® IgM FITC conjugate, Evans blue; 10 ml | 15 | 5 | 1 | 1 | 0 |
90-1048 | Biosorb® IgM/IgA Isolations, 48 isolations | 13 | 0 | 1 | 1 | 0 |
90-1120 | Biosorb® IgM/IgA Isolations, 120 isolations | 16 | 3 | 1 | 2 | 0 |
21130507K | Biosave® IM ab latex kit, heterophil ab with infectious mononucleosis | 14 | 4 | 6 | 4 | 0 |
01C65333F | Biognost® Influenza A FITC conjugate, MAB | 8 | 1 | 2 | 1 | 0 |
IA-1102 | Biognost® Influenza A IgM, positive control | 13 | 2 | 1 | 1 | 0 |
QAB-1504 | Biognost® Influenza A/B ag control slide, 1 well IA, 1 well IB infected, 2 wells non infected cells | 15 | 4 | 2 | 2 | 0 |
01C65133F | Biognost® Influenza B FITC conjugate, MAB | 13 | 2 | 3 | 2 | 0 |
IA-1101 | Biognost® Influenza virus A IgG, positive control | 15 | 2 | 1 | 2 | 0 |
IA-1112 | Biognost® Influenza virus A slide, 12 wells | 13 | 4 | 1 | 1 | 0 |
IB-2101 | Biognost® Influenza virus B IgG, positive control | 12 | 1 | 1 | 1 | 0 |
IB-2102 | Biognost® Influenza virus B IgM, positive control | 14 | 0 | 1 | 2 | 0 |
IB-2112 | Biognost® Influenza virus B slide, 12 wells | 15 | 3 | 2 | 1 | 0 |
152305 | Biognost® Legionella Ab negative FITC conjugate, Evans blue; 0.5 ml | 13 | 1 | 1 | 1 | 0 |
71001 | Biognost® Legionella pneumophila ab, positive control | 16 | 5 | 2 | 4 | 0 |
152105 | Legionella pneumophila SG 1-6, FITC conjugate, Evans blue | 16 | 3 | 1 | 2 | 0 |
7020 | Biognost® Legionella pneumophila SG 1-6 control slide, each serogroup on 2 vertical wells | 13 | 1 | 3 | 1 | 0 |
7103 | Biognost® Legionella pneumophila SG 1-6 slide, all wells contain a mixture of all SG 1-6; 6 wells | 16 | 3 | 5 | 6 | 0 |
7104 | Biognost® Legionella pneumophila SG 1-6 slide, all wells contain a mixture of all SG 1-6; 12 wells | 14 | 0 | 2 | 7 | 0 |
50-3001 | Biognost® Leishmania donovani IgG, positive control | 14 | 2 | 3 | 5 | 0 |
50-3006 | Biognost® Leishmania donovani slide, 6 wells | 15 | 4 | 3 | 6 | 0 |
11130507K | Biosave® Leptospira ab latex kit, Agglutination | 14 | 0 | 1 | 3 | 0 |
31-1001 | Biognost® Leptospira interrogans IgG, positive control | 15 | 4 | 3 | 6 | 0 |
31-1002 | Biognost® Leptospira interrogans IgM, positive control | 15 | 3 | 2 | 3 | 0 |
31-1006 | Biognost® Leptospira interrogans slide, 6 wells | 17 | 5 | 4 | 3 | 0 |
33-1001 | Biognost® Listeria monocytogenes 1 IgG, positive control | 15 | 2 | 3 | 8 | 0 |
33-1002 | Biognost® Listeria monocytogenes 1 IgM, positive control | 16 | 3 | 1 | 3 | 0 |
33-2001 | Biognost® Listeria monocytogenes 4b IgG, positive control | 15 | 3 | 3 | 10 | 0 |
33-2002 | Biognost® Listeria monocytogenes 4b IgM, positive control | 15 | 4 | 2 | 3 | 0 |
33-1006 | Biognost® Listeria monocytogenes type 1 slide, 6 wells | 15 | 7 | 4 | 4 | 0 |
33-2006 | Biognost® Listeria monocytogenes type 4b slide, 6 wells | 14 | 5 | 5 | 5 | 0 |
2203 | Biognost® LKM, positive control | 14 | 0 | 1 | 12 | 0 |
ME-6001 | Biognost® Measles virus IgG, positive control | 16 | 5 | 2 | 3 | 0 |
ME-6002 | Biognost® Measles virus IgM, positive control | 16 | 5 | 5 | 1 | 0 |
ME-6006 | Biognost® Measles virus slide, 6 wells | 16 | 2 | 7 | 5 | 0 |
ME-6012 | Biognost® Measles virus slide, 12 wells | 15 | 0 | 2 | 5 | 0 |
A124 | Biognost® Monkey ovary ab slide, Monkey ovary sections; 4 wells | 13 | 1 | 2 | 2 | 0 |
A024 | Biognost® Monkey sciatic nerve sections slide, 4 wells | 13 | 2 | 1 | 1 | 0 |
1610 | Biognost® Mounting medium, 1,5 ml | 12 | 21 | 2 | 5 | 0 |
161010 | Biognost® Mounting medium, 10 ml | 15 | 24 | 1 | 0 | 0 |
MU-8001 | Biognost® Mumps virus IgG, positive control | 15 | 2 | 0 | 6 | 0 |
MU-8002 | Biognost® Mumps virus IgM, positive control | 12 | 3 | 1 | 3 | 0 |
MU-8006 | Biognost® Mumps virus slide, 6 wells | 15 | 4 | 0 | 7 | 0 |
MU-8012 | Biognost® Mumps virus slide, 12 wells | 14 | 2 | 1 | 5 | 0 |
MP-1204 | Biognost® Mycoplasma pneumoniae IgA, positive control | 2 | 2 | 2 | 2 | 0 |
MP-1201 | Biognost® Mycoplasma pneumoniae IgG, positive control | 18 | 7 | 4 | 3 | 0 |
MP-1202 | Biognost® Mycoplasma pneumoniae IgG, positive control | 15 | 7 | 2 | 5 | 0 |
MP-1206 | Biognost® Mycoplasma pneumoniae slide, 6 wells | 16 | 8 | 4 | 6 | 0 |
MP-1212 | Biognost® Mycoplasma pneumoniae slide, 12 wells | 14 | 3 | 1 | 15 | 0 |
6202 | Biognost® nDNA Ab, positive control, 0.09% NaN3 | 16 | 2 | 2 | 5 | 0 |
6006 | Biognost® nDNA slide, Crithidia luciliae; 6 wells | 16 | 2 | 4 | 12 | 0 |
1111I | Biognost®/Biosave® Negative control, infectious serology | 14 | 53 | 3 | 4 | 0 |
A12402 | Biognost® Ovary / testis ab, positive control | 13 | 0 | 1 | 2 | 0 |
7602 | Biognost® P-ANCA, positive control | 17 | 3 | 1 | 4 | 0 |
7706 | Biognost® P-ANCA slide, formalin fixed human neutrophil granulocytes; 6 wells | 16 | 4 | 5 | 7 | 0 |
P1-7102 | Biognost® Parainfluenza virus 1 IgM, positive control | 13 | 1 | 0 | 3 | 0 |
P1-7112 | Biognost® Parainfluenza virus 1 slide, 12 wells | 12 | 0 | 2 | 1 | 0 |
PI-3101 | Biognost® Parainfluenza virus 1-3 IgG, positive control | 15 | 5 | 2 | 2 | 0 |
P2-8112 | Biognost® Parainfluenza virus 2 slide, 12 wells | 15 | 0 | 2 | 2 | 0 |
P3-9112 | Biognost® Parainfluenza virus 3 slide, 12 wells | 15 | 4 | 1 | 1 | 0 |
QP-8506 | Biognost® Parainfluenzavirus 1-3 ag control slide, 3 wells infected, 3 wells uninfected | 16 | 0 | 1 | 3 | 0 |
P2-8102 | Biognost® Parainfluenzavirus 2 IgM, positive control | 15 | 2 | 0 | 2 | 0 |
P3-9102 | Biognost® Parainfluenzavirus 2 IgM, positive control | 0 | 1 | 0 | 0 | 0 |
2904 | Biognost® Paraneoplastic pemphigus Ab slide, Rat bladder sections; 4 wells | 14 | 1 | 5 | 2 | 0 |
2902 | Biognost® Paraneoplastic pemphigus IgG, positive control | 13 | 2 | 3 | 1 | 0 |
V119BIF01 | Biognost® Parvovirus B19 IgG, positive control | 15 | 2 | 5 | 3 | 0 |
V119BIF02 | Biognost® Parvovirus B19 IgM, positive control | 6 | 3 | 6 | 0 | 0 |
V1019IFS | Biognost® Parvovirus B19 slide, 10 wells | 14 | 3 | 4 | 3 | 0 |
1605 | Biognost® PBS buffer powder, for 4x 500 ml PBS solution | 14 | 16 | 2 | 1 | 0 |
1606 | Biognost® PBS buffer powder, for 2x 1000 ml PBS solution | 11 | 27 | 6 | 7 | 0 |
A134 | Biognost® Pituitary gland ab slide, Monkey pituitary gland sections, 4 wells | 12 | 1 | 0 | 1 | 0 |
1500 | Biognost® Polyspecific FITC conjugate, 2 ml | 12 | 0 | 1 | 2 | 0 |
1512 | Biognost® Polyspecific FITC conjugate, monkey tissue; 2 ml | 11 | 3 | 1 | 0 | 0 |
1501P | Biognost® Polyspecific FITC conjugate, Evans blue; 2 ml | 13 | 0 | 2 | 1 | 0 |
15244 | Biognost® Polyspecific FITC conjugate, Legionella Ab, conc., 1:4; 2 ml | 13 | 0 | 1 | 5 | 0 |
15300 | Biognost® Polyspecific FITC conjugate, 3 ml | 13 | 1 | 0 | 0 | 0 |
15301 | Biognost® Polyspecific FITC conjugate, Evans blue; 3 ml | 13 | 1 | 0 | 2 | 0 |
15302 | Biognost® Polyspecific FITC conjugate, monkey tissue, Evans blue; 3 ml | 14 | 0 | 1 | 1 | 0 |
15312 | Biognost® Polyspecific FITC conjugate, monkey tissue; 3 ml | 15 | 8 | 1 | 2 | 0 |
15324 | Biognost® Polyspecific FITC conjugate, Legionella ab; 3 ml | 12 | 3 | 2 | 1 | 0 |
151000 | Biognost® Polyspecific FITC conjugate, 10 ml | 15 | 8 | 1 | 1 | 0 |
151001 | Biognost® Polyspecific FITC conjugate, Evans blue; 10 ml | 9 | 0 | 1 | 0 | 0 |
151002 | Polyspecific FITC conjugate, monkey tissue, Evans blue; 10 ml | 12 | 2 | 1 | 1 | 0 |
15301P | Biognost® Polyspecific FITC conjugate, Evans blue; 3 ml | 15 | 1 | 0 | 2 | 0 |
36-6105 | Biosorb® Reiter-Spirochete absorbens, spirochete ab, 0.09% NaN3 | 17 | 1 | 3 | 6 | 0 |
RS-9006 | Biognost® Respiratory syncytial virus (RSV) slide, 6 wells | 17 | 6 | 2 | 2 | 0 |
RS-9012 | Biognost® Respiratory syncytial virus (RSV) slide, 12 wells | 13 | 2 | 2 | 0 | 0 |
QRP-6314 | Biognost® Respiratory viruses ag control slide, 7 infected wells, 7 uninfected wells | 13 | 3 | 2 | 2 | 0 |
QRS-9002 | Biognost® RSV ag control slide, 1 well infected, 1 well uninfected cells | 15 | 2 | 2 | 2 | 0 |
01C65066F | Biognost® RSV FITC conjugate, MAB | 15 | 2 | 2 | 6 | 0 |
RS-9004 | Biognost® RSV IgA, positive control | 16 | 2 | 2 | 2 | 0 |
RS-9001 | Biognost® RSV IgG, positive control | 17 | 2 | 2 | 2 | 0 |
RS-9002 | Biognost® RSV IgM, positive control | 16 | 3 | 2 | 1 | 0 |
6302 | Biognost® Salivary duct ab, positive control | 14 | 1 | 3 | 6 | 0 |
6304 | Biognost® Salivary gland Ab slide, Monkey salivary gland sections; 4 wells | 14 | 2 | 2 | 4 | 0 |
3202 | Biognost® SMA, positive control | 13 | 3 | 1 | 2 | 0 |
3004 | Biognost® SMA/PCA slide, rat stomach sections, 4 wells | 14 | 1 | 9 | 15 | 0 |
5802 | Biognost® Striated muscle ab, positive control | 16 | 1 | 5 | 3 | 0 |
5804 | Biognost® Striated muscle ab slide, monkey striated muscle sections; 4 wells | 14 | 3 | 3 | 15 | 0 |
A054 | Biognost® Testis ab slide, Monkey testis sections; 4 wells | 14 | 1 | 3 | 4 | 0 |
1000501 | Biognost® Trichinella spiralis Ab, positive control | 14 | 1 | 0 | 0 | 0 |
10005 | Biognost® Trichinella spiralis slide, 6 wells | 10 | 0 | 1 | 1 | 0 |
50-4001 | Biognost® Trypanosoma cruzi IgG, positive control | 15 | 3 | 1 | 3 | 0 |
50-4006 | Biognost® Trypanosoma cruzi slide*, 6 wells; *substrate T. bennetti and T. lewisi | 14 | 3 | 5 | 4 | 0 |
VZ-7006 | Biognost® Varicella zoster virus (VZV) slide, 6 wells | 16 | 4 | 9 | 7 | 0 |
VZ-7012 | Biognost® Varicella zoster virus (VZV) slide, 12 wells | 13 | 2 | 5 | 3 | 0 |
VZ-7004 | Biognost® Varizella zoster Virus IgA, positive control | 15 | 0 | 2 | 3 | 0 |
VZ-7001 | Biognost® Varizella zoster virus IgG, positive control | 16 | 3 | 1 | 3 | 0 |
VZ-7002 | Biognost® Varizella zoster Virus IgM, positive control | 17 | 5 | 2 | 2 | 0 |
QVZ-7002 | Biognost® VZV ag control slide, 1 well infected, one well uninfected cells | 17 | 0 | 3 | 3 | 0 |
01C05108F | Biognost® VZV FITC conjugate, MAB | 14 | 1 | 4 | 2 | 0 |
7604 | Biognost® X-ANCA, positive control | 14 | 0 | 1 | 1 | 0 |
7806 | Biognost® X-ANCA slide, methanol fixed human neutrophil granulocytes | 15 | 1 | 2 | 4 | 0 |
35-1004 | Biognost® Yersinia enterocolitica IgA, positive control | 15 | 3 | 1 | 1 | 0 |
35-1001 | Biognost® Yersinia enterocolitica IgG, positive control | 17 | 3 | 2 | 3 | 0 |
35-1006 | Biognost® Yersinia enterocolitica slide, 6 wells | 18 | 2 | 3 | 1 | 0 |